Last reviewed · How we verify

NCT04277728: MissPerfeCT

Hypoperfusion-hypodensity Mismatch for the Identification of Patients With Stroke Within 4.5 Hours

Completed Last updated 20 February 2020
What this trial tests

trial testing hypoperfusion-hypodensity mismatch in Acute Ischemic Stroke in 689 participants. Completed in 31 December 2019.

Timeline
1 January 2018
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorUniversity Hospital Muenster
StatusCompleted
Study typeOBSERVATIONAL
Enrollment689
Start date1 January 2018
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Muenster

Who can join

18 and older, any sex, with Acute Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intravenous thrombolysis is recommended within 4.5 hours of stroke onset. The aim of the study is to evaluate whether a hypodensity on native CT within the virtually entire area of hypoperfusion on perfusion CT, i.e. hypoperfusion-hypodensity mismatch, identifies patients within the time window of thrombolysis in a multicenter cohort. The investigators hypothesize hypoperfusion-hypodensity mismatch will identify patients ≤ 4,5 hours of symptom onset with \>70% specificity and \>85% positive predictive value.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. CT Hypoperfusion-Hypodensity Mismatch to Identify Patients With Acute Ischemic Stroke Within 4.5 Hours of Symptom Onset.
    Sporns PB, Kemmling A, Minnerup H, Meyer L, et al · · 2021 · cited 9× · PMID 34649883 · DOI 10.1212/wnl.0000000000012891
  2. Simplified Assessment of Lesion Water Uptake for Identification of Patients within 4.5 Hours of Stroke Onset: An Analysis of the MissPerfeCT Study.
    Sporns PB, Höhne M, Meyer L, Krogias C, et al · · 2022 · cited 3× · PMID 36221942 · DOI 10.5853/jos.2022.00220
  3. Computed tomography hypoperfusion-hypodensity mismatch vs. automated perfusion mismatch to identify stroke patients eligible for thrombolysis.
    Sporns PB, Kemmling A, Meyer L, Krogias C, et al · · 2023 · PMID 38225983 · DOI 10.3389/fneur.2023.1320620

Verify or expand the search:

Other recruiting trials for Acute Ischemic Stroke

Currently open trials in the same condition.

Other University Hospital Muenster trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04277728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing